
Oura Health Oy, the maker of the Oura Ring, is reportedly closing a Series E financing round of $875 million, which would value the company at approximately $10.9 billion. This valuation more than doubles its $5 billion valuation from last November, reflecting significant growth driven by the sale of around 3 million rings over the past year and underscoring strong investor confidence in the health and fitness wearable sector.
Oura Health Oy is reportedly securing an $875 million Series E financing round, which would elevate its valuation to approximately $10.9 billion. This represents a significant valuation uplift, more than doubling its $5 billion valuation from its Series D round in November of the previous year. This rapid appreciation is directly linked to strong commercial momentum, highlighted by the sale of roughly 3 million units over the past year. The successful fundraising at such a premium underscores robust investor confidence in the high-growth health and fitness wearable sector, particularly for companies with strong hardware sales and potential data-driven subscription models. The capital injection at this late stage positions Oura for aggressive expansion and solidifies its status as a major player in the private technology and healthcare markets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85